Prostaglandin D2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways

European Journal of Immunology

Volumn 33, Issue 4, 2003, Pages 889-898

  Faveeuw, Christelle ^a   Gosset, Philippe ^a   Bureau, Fabrice ^b   Angeli, Véronique ^a   Hirai, Hiroyuki ^c   Maruyama, Takayuki ^d   Narumiya, Shuh ^e   Capron, Monique ^a   Trottein, François ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c BML   (Japan)

^d ONO PHARMACEUTICAL CO   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

D prostanoid receptor; Dendritic cell; IL 12; NF B; Prostaglandin D2

Indexed keywords

CD40 ANTIGEN; CELL PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; PROSTAGLANDIN D2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN J2; PROSTANOID RECEPTOR; 15 DEOXY DELTA(12,14) PROSTAGLANDIN J2; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J2; CD40 LIGAND; CYCLIC AMP; DRUG DERIVATIVE; IMMUNOGLOBULIN RECEPTOR; MESSENGER RNA; PROSTAGLANDIN D2 RECEPTOR; PROSTAGLANDIN RECEPTOR;

ANIMAL CELL; ANTIGEN PRESENTING CELL; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOSE RESPONSE; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; SPLEEN CELL; TH1 CELL; ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECT; FEMALE; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SPLEEN;

ANIMALS; CD40 LIGAND; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; NF-KAPPA B; PROSTAGLANDIN D2; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPLEEN;

EID: 0038744603     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323330     Document Type: Review

References (43)

1. Urade, Y. and Hayaishi, O., Prostaglandin D synthase: structure and function. Vitam. Horm. 2000. 58: 89-120.
2. 2 as a mediator of allergic asthma. Science 2000. 287: 2013-2017.
3. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J. Exp. Med. 2001. 193: 255-261.
4. 2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 2001. 98: 1942-1948.
5. Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J. and Willoughby, D. A., Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 1999. 5: 698-701.
6. 2 is an early anti-inflammatory signal in experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2000. 279: 238-244.
7. Ianaro, A., Ialenti, A., Maffia, P., Pisano, B. and Di Rosa, M., Role of cyclopentenone prostaglandins in rat carrageenin pleurisy. FEBS Lett. 2001. 508: 61-66.
8. Narumiya, S., Y. Sugimoto, Y. and Ushikubi, F., Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 1999. 79: 1193-1226.
9. 2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995. 83: 803-812.
10. 2 metabolite generated during inflammatory processes. J. Biol. Chem. 2002. 277: 10459-10466.
11. Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M. and Santoro, M. G., Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature 2000. 403: 103-108.
12. 2 inhibits multiple steps in the NF-κB signaling pathway. Proc. Natl. Acad. Sci. USA 2000. 97: 4844-4849.
13. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
14. Lanzavecchia, A. and Sallusto, F., The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr. Opin. Immunol. 2001. 3:291-298.
15. 2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J. Exp. Med. 2001. 193: 1138-1148.
16. Trinchieri, G. and Scott, P., Interleukin-12: a proinflammatory cytokine with immunoregulatory functions. Res. Immunol. 1995. 146: 423-431.
17. Celia, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A. and Alber, G., Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 1996. 184: 747-752.
18. α cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J. Exp. Med. 1997. 186: 1603-1608.
19. 2 is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 2001. 97: 3466-3469.
20. Aloisi, F., Penna, G., Cerase, J., Menendez Iglesias, B. and Adorini, L., IL-12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 1997. 159: 1604-1612.
21. Staples, K. J., Bergmann, M., Tamita, K., Houslay, M. D., McPhee, I., Barnes, P. J., Glembycz, M. A. and Newton, R., Adenosine 3′,5′-cyclic monophosphate (cAMP)-dependent inhibition of IL-5 from human T lymphocytes is not mediated by the cAMP-dependent protein kinase A. J. Immunol. 2001. 167: 2074-2080.
22. Martin, M. C., Dransfield, I., Haslett, C. and Rossi, A. G., Cyclic AMP regulation of neutrophil apoptosis occurs via a novel protein kinase A-independent signaling pathway. J. Biol. Chem. 2001. 276: 45041-4550.
23. Francis, S. H. and Corbin, J. D., Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action. Crit. Rev. Clin. Lab. Sci. 1999. 36: 275-328.
24. Nedachi, T., Akahori, M., Ariga, M., Sakamoto, H., Suzuki, N., Umesaki, K., Hakuno, F. and Takahashi, S. I., Tyrosine kinase and phosphatidylinositol 3-kinase activation are required for cyclic adenosine 3′,5′-monophosphate-dependent potentiation of deoxyribonucleic acid synthesis induced by insulin-like growth factor-I in FRTL-5 cells. Endocrinology 2000. 141: 2429-2438.
25. Erhardt, P., Troppmair, J., Rapp, U. R. and Cooper, G. M., Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells. Mol. Cell. Biol. 1995. 15: 5524-5530.
26. Plevin, R., Malarkey, K., Aidulis, D., McLees, A. and Gould, G. W., Cyclic AMP inhibitors inhibits PDGF-stimulated mitogen-activated protein kinase activity in rat aortic smooth muscle cells via inactivation of c-Raf-1 kinase and induction of MAP kinase phosphatase-1. Cell. Signal. 1997. 9: 323-328.
27. 2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. J. Immunol. 1989. 143: 2982-2989.
28. 2 by human helper T cell subsets. J. Immunol. 2000. 164: 2277-2280.
29. Jonuleit, H., Kuhn, U., Muller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J. and Enk, A. H., Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 1997. 27: 3135-3142.
30. Steinbrink, K., Paragnik, L., Jonuleit, H., Tuting, T., Knop, J. and Enk, A. H., Induction of dendritic cell maturation and modulation of dendritic cell-induced immune responses by prostaglandins. Arch. Dermatol. Res. 2000. 292: 437-445.
31. 2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 1997. 159: 28-35.
32. + dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 1998. 161: 2804-2809.
33. + dendritic cells that induce Th2 cell development. Blood 2001. 98: 2489-2497.
34. Wright, D. H., Metters, K. M., Abramovitz, M. and Ford-Hutchinson, A. W., Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist. Br. J. Pharmacol. 1998. 123: 1317-1324.
35. 2 are potent activators of human eosinophils. J. Immunol. 2002. 168: 3563-3569.
36. 2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat. Med. 2002. 8: 289-293.
37. Tilley, S. L., Coffman, T. M. and Koller, B. H., Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 2001. 108: 15-23.
38. 2 inhibits IL-10 and IL-12 production by macrophages. Biochem. Biophys. Res. Commun. 2001. 283: 344-346.
39. Faveeuw, C., Fougeray, S., Angeli, V., Fontaine, J., Chinetti, G., Gosset, P., Delerive, P., Maliszewski, C., Capron, M., Staels, B., Moser, M. and Trottein, F., Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells. FEBS Lett. 2000. 486: 261-266.
40. Gosset, P., Charbonnier, A. S., Delerive, P., Fontaine, J., Staels, B., Pestel, J., Tonnel, A. B. and Trottein, F., Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells. Eur. J. Immunol. 2001. 31: 2857-2865.
41. Murphy, T. L., Cleveland, M. G., Kulesza, P., Magram, J. and Murphy, K. M., Regulation of interleukin 12 p40 expression through an NF-κB half-site. Mol. Cell. Biol. 1995. 15: 5258-5267.
42. Bureau, F., Delhalle, S., Bonizzi, G., Fievez, L., Dogne, S., Kirschvink, N., Vanderplasschen, A., Merville, M. P., Bours, V. and Lekeux, P., Mechanisms of persistent NF-κB activity in the bronchi of an animal model of asthma. J. Immunol. 2000. 165: 5822-5830.
43. Parry, G. C. and Mackman, N., Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-κB-mediated trancription. J. Immunol. 1997. 159: 5450-5456.